Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2003-08-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.1434398100PMID 12939405PMCID PMC196910
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased Expression of Neuronal Apolipoprotein E in Human Brain With Cerebral Infarction

  2003cited by this paper
• Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis.

  2002cited by this paper
• Truncated apoE forms tangle-like structures in a neuronal cell line

  2002cited by this paper
• APOE: A potential marker of disease progression in ALS

  2002cited by this paper
• Age at onset of Parkinson disease and apolipoprotein E genotypes.

  2002cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• Quantitation of apoE Domains in Alzheimer Disease Brain Suggests a Role for apoE in Aß Aggregation

  2001cited by this paper
• Synthesis and processing of apolipoprotein E in human brain cultures

  2001cited by this paper
• Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology.

  2001cited by this paper
• Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons

  2001cited by this paper
• Analysis of tauopathies with transgenic mice.

  2001cited by this paper
• Plasma lipids and their role in disease

  2000cited by this paper
• Alzheimer's disease: Apolipoprotein E and cognitive performance

  2000cited by this paper
• Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease.

  2000cited by this paper
• Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice.

  2000cited by this paper
• Apolipoprotein E receptors: linking brain development and alzheimer's disease

  2000cited by this paper
• Apolipoprotein E: far more than a lipid transport protein.

  2000cited by this paper
• Hypothalamic–Pituitary–Adrenal Dysfunction inApoe−/− Mice: Possible Role in Behavioral and Metabolic Alterations

  2000cited by this paper
• Synthesis and regulation of apolipoprotein E during the differentiation of human neuronal precursor NT2/D1 cells into postmitotic neurons.

  2000cited by this paper
• Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid β-peptide deposition in homozygous APPV717F transgenic mice

  2000cited by this paper
• Truncated Apolipoprotein E (ApoE) Causes Increased Intracellular Calcium and May Mediate ApoE Neurotoxicity

  1999cited by this paper
• Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease.

  1999cited by this paper
• Sialylated human apolipoprotein E (apoEs) is preferentially associated with neuron-enriched cultures from APOE transgenic mice.

  1999cited by this paper
• Expression of Human Apolipoprotein E3 or E4 in the Brains ofApoe−/− Mice: Isoform-Specific Effects on Neurodegeneration

  1999cited by this paper
• Specific regional transcription of apolipoprotein E in human brain neurons.

  1999cited by this paper
• Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond.

  1999cited by this paper
• Apolipoprotein E expression by neurons surviving excitotoxic stress.

  1999cited by this paper
• Plasma Lipids and Their Role in Disease

  1999cited by this paper
• Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females.

  1998cited by this paper
• Neurotoxicity of the 22 kDa Thrombin-Cleavage Fragment of Apolipoprotein E and Related Synthetic Peptides Is Receptor-Mediated

  1997cited by this paper
• ApoE synthesis in human neuroblastoma cells.

  1997cited by this paper
• Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis

  1997cited by this paper
• Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

  1997cited by this paper
• Apolipoprotein E, Plaques, Tangles and Cholinergic Dysfunction in Alzheimer's Disease a

  1996cited by this paper
• Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice.

  1996cited by this paper
• Expression of apolipoprotein E in normal and diverse neurodegenerative disease brain.

  1996cited by this paper
• Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides

  1996cited by this paper
• Neurons of the Human Frontal Cortex Display Apolipoprotein E Immunoreactivity: Implications for Alzheimer's Disease

  1996cited by this paper
• What do dysfunctional serpins tell us about molecular mobility and disease?

  1995cited by this paper
• Carbonyl‐Related Posttranslational Modification of Neurofilament Protein in the Neurofibrillary Pathology of Alzheimer's Disease

  1995cited by this paper
• The Inhibitory Effect of Apolipoprotein E4 on Neurite Outgrowth Is Associated with Microtubule Depolymerization (*)

  1995cited by this paper
• Apolipoprotein E Is Localized to the Cytoplasm of Human Cortical Neurons: A Light and Electron Microscopic Study

  1994cited by this paper
• Apolipoprotein E Affects the Rate of Alzheimer Disease Expression: (β-Amyloid Burden Is a Secondary Consequence Dependent on APOE Genotype and Duration of Disease

  1994cited by this paper
• Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro.

  1994cited by this paper
• Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease.

  1994cited by this paper
• Isoform-specific binding of apolipoprotein E to beta-amyloid.

  1994cited by this paper
• Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments.

  1994cited by this paper
• Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro.

  1994cited by this paper
• Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease.

  1994cited by this paper
• Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

  1994cited by this paper
• Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

  1993cited by this paper
• Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

  1993cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• Tau protein and paired helical filaments of Alzheimer's disease

  1993cited by this paper
• Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid.

  1992cited by this paper
• The molecular pathology of Alzheimer's disease.

  1991cited by this paper
• Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes

  1991cited by this paper
• Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning.

  1991cited by this paper
• Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

  1991cited by this paper
• Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.

  1988cited by this paper
• Stroke: Pathophysiology, Diagnosis, and Management, vols. 1 and 2

  1987cited by this paper
• Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system.

  1985cited by this paper
• Monoclonal antibodies to the low density lipoprotein receptor as probes for study of receptor-mediated endocytosis and the genetics of familial hypercholesterolemia.

  1981cited by this paper

• Mitochondrial complex-derived ROS induces lysosomal dysfunction and impairs autophagic flux in human cells carrying the APOE4 allele.

  2026cites this paper
• Increased Concentration of Anti-Egg Albumin Antibodies in Cerebrospinal Fluid and Serum of Patients with Alzheimer’s Disease—Discussion on Human Serpins’ Similarity and Probable Involvement in the Disease Mechanism

  2025cites this paper
• Conformational Features of Guinea Pig Apolipoprotein E Offer Insights into Functioning of Human Apolipoprotein E.

  2025cites this paper
• Differential Effects of Aβ Peptides on the Plasmin-Dependent Degradation of ApoE3 and ApoE4.

  2025cites this paper
• Association of Alzheimer’s Disease Polygenic Risk Score with Concussion Severity and Recovery Metrics

  2025cites this paper
• A manifesto for Alzheimer’s disease drug discovery in the era of disease-modifying therapies

  2025cites this paper
• Neuronal APOE4 alone is sufficient to drive tau pathology, neurodegeneration, and neuroinflammation in an Alzheimer’s disease mouse model

  2025cites this paper
• Genetic and environmental risk factors for dementia in African adults: A systematic review

  2025cites this paper
• Early- and Late-Onset Alzheimer’s Disease: Two Sides of the Same Coin?

  2024cites this paper
• New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer’s disease

  2024cites this paper
• Multiple Roles of Apolipoprotein E4 in Oxidative Lipid Metabolism and Ferroptosis During the Pathogenesis of Alzheimer’s Disease

  2024cites this paper
• Role of mitochondria‐endoplasmic reticulum contacts in neurodegenerative, neurodevelopmental and neuropsychiatric conditions

  2024cites this paper
• Unraveling APOE4's Role in Alzheimer's Disease: Pathologies and Therapeutic Strategies.

  2024cites this paper
• Cell type-specific roles of APOE4 in Alzheimer disease

  2024cites this paper
• Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia

  2024cites this paper
• Prevalence of ApoE Alleles in a Spanish Population of Patients with a Clinical Diagnosis of Alzheimer’s Disease: An Observational Case-Control Study

  2024cites this paper
• The Contributions of the Endolysosomal Compartment and Autophagy to APOEɛ4 Allele-Mediated Increase in Alzheimer’s Disease Risk

  2024cites this paper
• CCR5 deficiency: Decreased neuronal resilience to oxidative stress and increased risk of vascular dementia

  2023cites this paper
• Cross interactions between Apolipoprotein E and amyloid proteins in neurodegenerative diseases

  2023influential citation
• Alzheimer's Disease; Mechanism, Mutations, and Applications of Nano-Medicine.

  2023cites this paper
• Cognitive impairment in long-living adults: a genome-wide association study, polygenic risk score model and molecular modeling of the APOE protein

  2023cites this paper
• Targeting apolipoprotein E and N-terminal amyloid β-protein precursor interaction improves cognition and reduces amyloid pathology in Alzheimer’s mice

  2023cites this paper
• Apolipoprotein E4 targets mitochondria and the mitochondria-associated membrane complex in neuropathology, including Alzheimer's disease.

  2023cites this paper
• Alzheimer's disease phenotype based upon the carrier status of the apolipoprotein E ɛ4 allele

  2023cites this paper
• Current biomarkers and treatment strategies in Alzheimer disease: An overview and future perspectives

  2023cites this paper
• Quantitative Proteomic Analysis Reveals apoE4-Dependent Phosphorylation of the Actin-Regulating Protein VASP

  2023cites this paper
• Functional diversity of apolipoprotein E: from subcellular localization to mitochondrial function

  2022cites this paper
• From degenerative disease to malignant tumors: Insight to the function of ApoE.

  2022cites this paper
• A multi‐hit hypothesis for an APOE4‐dependent pathophysiological state

  2022cites this paper
• Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets

  2022cites this paper
• Effects of toxic apolipoprotein E fragments on Tau phosphorylation and cognitive impairment in neonatal mice under sevoflurane anesthesia

  2022cites this paper
• Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease.

  2022cites this paper
• Apolipoprotein E in Cardiometabolic and Neurological Health and Diseases

  2022cites this paper
• BOISE STATE UNIVERSITY GRADUATE COLLEGE DEFENSE COMMITTEE AND FINAL READING APPROVALS

  2022cites this paper
• A Haptoglobin (HP) Structural Variant Alters the Effect of APOE Alleles on Alzheimer’s Disease

  2022cites this paper
• Neurotoxic 18-kDa apolipoprotein E fragment production contributes to anesthetic sevoflurane-induced tau phosphorylation and neuroinflammation in vitro

  2022cites this paper
• Are apolipoprotein E fragments a promising new therapeutic target for Alzheimer’s disease?

  2022cites this paper
• An amino-terminal fragment of apolipoprotein E4 leads to behavioral deficits, increased PHF-1 immunoreactivity, and mortality in zebrafish

  2022cites this paper
• Aggregate Trends of Apolipoprotein E on Cognition in Transgenic Alzheimer’s Disease Mice

  2021cites this paper
• The plasma peptides of Alzheimer’s disease

  2021cites this paper
• Patient-derived iPSCs, a reliable in vitro model for the investigation of Alzheimer’s disease

  2021cites this paper
• Mechanistic insight into the capacity of natural polar phenolic compounds to abolish Alzheimer's disease-associated pathogenic effects of apoE4 forms.

  2021cites this paper
• Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation

  2021cites this paper
• Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer’s disease

  2021cites this paper
• A Tau-Driven Adverse Outcome Pathway Blueprint Toward Memory Loss in Sporadic (Late-Onset) Alzheimer’s Disease with Plausible Molecular Initiating Event Plug-Ins for Environmental Neurotoxicants

  2021cites this paper
• Perspectives on the Role of APOE4 as a Therapeutic Target for Alzheimer’s Disease

  2021cites this paper
• Altered substrate metabolism in neurodegenerative disease: new insights from metabolic imaging

  2021cites this paper
• Apolipoprotein E and Alzheimer's disease

  2021cites this paper
• Modifier Genes as a Cause of Wilson–Konovalov Disease Clinical Polymorphism

  2021cites this paper
• Isoform-Specific Effects of Apolipoprotein E on Markers of Inflammation and Toxicity in Brain Glia and Neuronal Cells In Vitro

  2021cites this paper
• Fragmentation of Apolipoprotein E4 is Required for Differential Expression of Inflammation and Activation Related Genes in Microglia Cells.

  2021cites this paper
• N-Terminomics Strategies for Protease Substrates Profiling

  2021cites this paper
• Exploring Relationships in Alzheimer’s APOE Transgenic Mice

  2021cites this paper
• Precision Nutrition for Alzheimer’s Prevention in ApoE4 Carriers

  2021cites this paper
• APP-Induced Patterned Neurodegeneration Is Exacerbated by APOE4 in Caenorhabditis elegans

  2020cites this paper
• Fragmentation of brain apolipoprotein E (ApoE) and its relevance in Alzheimer's disease

  2020cites this paper
• Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer's Disease

  2020cites this paper
• High‐density lipoprotein‐related cholesterol metabolism in Alzheimer’s disease

  2020cites this paper
• Apolipoprotein E and Alzheimer’s disease: the influence of apolipoprotein E on amyloid-  and other amyloidogenic proteins

  2020cites this paper
• APOE4 genetic polymorphism results in impaired recovery in a repeated mild traumatic brain injury model and treatment with Bryostatin-1 improves outcomes

  2020cites this paper
• Bioinformatics Review of the Role of HSV-1 in Alzheimer’s Disease

  2020cites this paper
• Common aspects between glaucoma and brain neurodegeneration.

  2020cites this paper
• Using human induced pluripotent stem cells (hiPSCs) to investigate the mechanisms by which Apolipoprotein E (APOE) contributes to Alzheimer's disease (AD) risk.

  2020cites this paper
• Executive Function Deficit as a Precursor to Memory Impairments in hApoE4 Transgenic Rats

  2020cites this paper
• APOEɛ4-TOMM40L Haplotype Increases the Risk of Mild Cognitive Impairment Conversion to Alzheimer’s Disease

  2020cites this paper
• Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease

  2019cites this paper
• History and progress of hypotheses and clinical trials for Alzheimer’s disease

  2019cites this paper
• ApoE4 pathology in Alzheimer's disease from the perspective of organelle dysfunction in astrocytes

  2019cites this paper
• Method optimization for Fourier transform infrared imaging of hippocampal sections from background and 3xTg (AD model) mice

  2019cites this paper
• Associations Between APOE Variants, Tau and α-Synuclein.

  2019cites this paper
• The carboxy-terminus, a key regulator of protein function

  2019cites this paper
• Modelling the neurobiology of Alzheimer’s disease in vitro

  2019cites this paper
• - 0101 Genetic Connections Between Neurological Disorders and Cholesterol Metabolism

  2019cites this paper
• A Biophysical Approach to the Identification of Novel ApoE Chemical Probes

  2019cites this paper
• ApoE-fragment/Aβ heteromers in the brain of patients with Alzheimer’s disease

  2019cites this paper
• An attempt to elucidate the role of iron and zinc ions in development of Alzheimer's and Parkinson's diseases.

  2019cites this paper
• γ-Oryzanol Improves Cognitive Function and Modulates Hippocampal Proteome in Mice

  2019cites this paper
• A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition.

  2019cites this paper
• New APOE-related therapeutic options for Alzheimer’s disease

  2019cites this paper
• Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors

  2019cites this paper
• Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.

  2019cites this paper
• Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies.

  2019cites this paper
• ApoE-associated modulation of neuroprotection from Aβ-mediated neurodegeneration in transgenic Caenorhabditis elegans

  2019cites this paper
• Neuron-Specific Apolipoprotein E4 (1-272) Fragment Induces Tau Hyperphosphorylation and Axonopathy via Triggering Endoplasmic Reticulum Stress

  2019cites this paper
• Targeting Apolipoprotein E for Alzheimer’s Disease: An Industry Perspective

  2019cites this paper
• Association between Apolipoprotein E Gene Polymorphism and Alzheimer's Disease in an Iranian Population: A Meta-Analysis

  2019cites this paper
• Lack of hepatic apoE does not influence early Aβ deposition: observations from a new APOE knock-in model

  2019cites this paper
• ApoE4: an emerging therapeutic target for Alzheimer’s disease

  2019cites this paper
• Apolipoprotein E Fragmentation within Lewy Bodies of the Human Parkinson’s Disease Brain

  2018cites this paper
• Understanding the Role of ApoE Fragments in Alzheimer’s Disease

  2018cites this paper
• The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis

  2018cites this paper
• Gain of toxic Apolipoprotein E4 effects in Human iPSC-Derived Neurons Is Ameliorated by a Small-Molecule Structure Corrector

  2018cites this paper
• Neurovascular dysfunction in vascular dementia, Alzheimer’s and atherosclerosis

  2018cites this paper
• APP-induced patterned neurodegeneration exacerbated by APOE4 in C. elegans

  2018cites this paper
• ApoE2-Mediated Neuroprotective Mechanism Through Up-regulation of Glycolysis

  2018cites this paper
• DNA methylation of TOMM40-APOE locus and Alzheimer’s disease pathology in the prefrontal cortex

  2018cites this paper
• APOE gene and neuropsychiatric disorders and endophenotypes: A comprehensive review

  2018influential citation
• A Dual Examination of Learning Through Pedagogical Training and Alzheimer's Disease Pathology

  2018cites this paper
• ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and Aβ production independently of their cholesterol efflux capacity.

  2018cites this paper
• Edinburgh Research Explorer APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease

  2018cites this paper